Skip to main content
U.S. flag

An official website of the United States government

Here’s how you know

.gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

HTTPS

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov. Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

Per Executive Order 14434, federal agencies are now using "Super Intelligence" (SI) in place of "Artificial Intelligence" (AI). You may see both terms during this transition.

Clinicalinfo.HIV.gov logo.
In affiliation with HIV.gov
Main navigation
  • Home
  • About
  • Guidelines
  • Drug Database
  • Glossary
  • News
  • Resources
  • Contact Us
  • English
  • Español (Spanish)
  1. Home
  2. Guidelines search

Search Guidelines

  • (-) Perinatal HIV Clinical Guidelines (93)
  • HIV Clinical Guidelines: Pediatric ARV (84)
  • (-) HIV Clinical Guidelines: Adult and Adolescent ARV (57)
  • HIV Clinical Guidelines: Pediatric Opportunistic Infections (44)
  • HIV Clinical Guidelines: Adult and Adolescent Opportunistic Infections (40)
  • Guidance for Caring for People With HIV Displaced by Disasters (4)
Search Results 21 – 40 of 150
Overview
Initial Evaluation and Continued Monitoring of HIV During Pregnancy
Antiretroviral Drug Resistance and Resistance Testing in Pregnancy
Laboratory Testing for Initial Assessment and Monitoring of People With HIV
Laboratory Testing
Treatment Goals
What to Start: Initial Antiretroviral Therapy Based on Specific Clinical Scenarios
Recommendations for Use of Antiretroviral Drugs During Pregnancy
Initiation of Antiretroviral Therapy
Recommendations for Use of Antiretroviral Drugs During Pregnancy: Overview
What to Start: Nucleoside Reverse Transcriptase Inhibitor Options
Use of Antiretroviral Drugs to Prevent Perinatal HIV Transmission and Improve Health During Pregnancy
What to Start: Integrase Strand Transfer Inhibitor Regimens
Antiretroviral Therapy When Trying to Conceive
What to Start: Non-Nucleoside Reverse Transcriptase Inhibitor Regimens
Initial Use of Antiretroviral Therapy During Pregnancy
When Antiretroviral Therapy Is Being Taken When Pregnancy Occurs
What to Start: Protease Inhibitor–Based Regimens
What to Start: Other Antiretroviral Regimens When Abacavir and Tenofovir Cannot Be Used or Are Not Optimal
Previous Experience With Antiretroviral Medications but Not Currently on Antiretroviral Therapy During Current Pregnancy

Pagination

  • First page ‹‹
  • Previous page ‹
  • Page 1
  • Current page 2
  • Page 3
  • Page 4
  • Page 5
  • …
  • Next page ›
  • Last page ››

CONNECT WITH US

Footer menu

  • Home
  • About
  • Guidelines
  • Drug Database
  • Glossary
  • News
  • Resources
  • Contact Us
  • Sponsors
  • Nondiscrimination Notice
  • Accessibility
  • Disclaimers
  • Sitemap
  • Privacy Policy
  • HHS Vulnerability Disclosure

External links

  • HIVinfo.NIH.gov
  • HHS.gov
  • NIH.gov
  • Players & Viewers
  • HHS 508
  • HHS Privacy Policy
  • Whitehouse.gov
  • USA.gov
  • Freedom of Information Act

Provided in collaboration with NIH’s Office of AIDS Research.